ObjectivesThe aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herb
Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant S. aureus with reduced susceptibility to oritavancin but minimal cross-resistance or seesaw effec